SCHEMBL24096237

SCHEMBL24096237

CSc1ncc2c(n1)CN(C1CCOCC1)C2=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GABRA1 P14867 2/20 0.42
▸ CCNA2 P20248 1/20 0.34
▸ CDK2 P24941 1/20 0.34
▸ MAOA P21397 2/20 0.34
▸ HTR2A P28223 2/20 0.33
▸ PIK3CG P48736 1/20 0.33
▸ PDE4B Q07343 3/20 0.33
▸ PIK3CA P42336 1/20 0.33
▸ MTOR P42345 1/20 0.33
▸ PARP1 P09874 1/20 0.33
▸ ALDH1A1 P00352 2/20 0.32
▸ DRD2 P14416 1/20 0.32
▸ DRD1 P21728 1/20 0.32
▸ DRD3 P35462 1/20 0.32
▸ PRKDC P78527 1/20 0.32
▸ KDM4E B2RXH2 2/20 0.32
▸ HPGD P15428 2/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ THRB P10828 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30272086 1.00 GABRA1 (0.42) GABRA1CCNA2CDK2MAOAHTR2A
SCHEMBL24096063 0.93 GABRA1 (0.37) GABRA1CCNA2CDK2MAOAHTR2A
SCHEMBL30272126 0.93 GABRA1 (0.37) GABRA1CCNA2CDK2MAOAHTR2A
SCHEMBL30272123 0.91 MAOA (0.39) GABRA1CCNA2CDK2MAOAHTR2A
SCHEMBL24096151 0.91 MAOA (0.39) GABRA1CCNA2CDK2MAOAHTR2A
SCHEMBL24096299 0.88 CCNA2 (0.39) CCNA2CDK2MAOAALDH1A1KDM4E
SCHEMBL30272103 0.88 CCNA2 (0.39) CCNA2CDK2MAOAALDH1A1KDM4E
SCHEMBL24096167 0.87 LRRK2 (0.36) GABRA1CCNA2CDK2MAOAHTR2A
SCHEMBL24096217 0.83 GABRA1 (0.38) GABRA1MAOAHTR2APARP1ALDH1A1
SCHEMBL24096155 0.82 KDM4E (0.32) CCNA2CDK2MAOAHTR2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230123268-A1 AMINO-PYRIMIDINE CYCLO-AMIDES HOFFMANN-LA ROCHE INC. (US) 2023-04-20 — — US disclosed
WO-2021249904-A2 AMINO-PYRIMIDINE CYCLO-AMIDES F. HOFFMANN-LA ROCHE AG (CH) 2021-12-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230123268-A1 AMINO-PYRIMIDINE CYCLO-AMIDES ATXN2, ATXN2L, ATXN10 GABRA1 2627/4885CCNA2 36/4885CDK2 8/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback